Guelph, Ont., September 28, 2017 – Mirexus Biotechnologies Inc. broke ground on their new facility today, two months after purchasing a 4.3 acre parcel of land in phase one of the Hanlon Creek Business Park.
The new facility will be located directly at the corner of Downey Road and Hanlon Creek Boulevard, producing a cutting edge corn-based biomaterial, PhytoSpherix®. The product is an ingredient used in the personal care and cosmetic industries.
“Mirexus chose Guelph as the prime location to establish their facility and we’re pleased they chose the Hanlon Creek Business Park to make their mark in our community,” says Barbara Maly, Manager, Economic Development. “Meeting the aggressive timelines of this project is a perfect example of how we’re making it easier for business to do business with the City.”
Mirexus Biotechnologies Inc. is part of Guelph’s globally recognized agri-innovation cluster which is home to over 350 agri-food and agri-biotechnology companies and associations. Staying local and true to their beginnings has been a focus of Mirexus, as research for their technology started at the University of Guelph. They’re working with local contractors such as Ramar Contractors Inc. (Guelph) and IFAB Engineering Partners LP (Cambridge) throughout the project. Having partners within a close proximity has helped streamline the process to get the shovel in the ground sooner. The company plans to be fully operational by June 2018.
“We have an accelerated timeline to bring the factory on line and we have been pressing the whole way,” says Trevor Jones, Vice President of Engineering at Mirexus Biotechnologies Inc. “The City has been very helpful in meeting all of our needs – it’s been a good ride so far.”
About Mirexus Biotechnologies Inc.
Mirexus Biotechnologies Inc. is a safe and natural biomaterials company based in Guelph, Ontario that is commercializing a novel nanotechnology, PhytoSpherix®. As a multifunctional additive, PhytoSpherix® can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to biomedical applications in animal and human health. This technology was originally developed at the University of Guelph by Professor John Dutcher.
About Invest in Guelph
Invest in Guelph represents the business development outcomes associated with the City of Guelph’s economic development strategy, Prosperity 2020. Its purpose is to position and promote Guelph, Ontario as an investment-ready and responsive community.
For more information
Barbara Maly, Manager, Economic Development
Business Development and Enterprise Services
City of Guelph
519-822-1260 extension 2822
Phil Whiting, President and Chief Executive Officer
Mirexus Biotechnologies Inc.
519-829-1221 extension 201